Skip to content

Clinical trials

Phase 2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Singapore Clear all

533 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20025
20035
200413
200516
200616
200722
200827
200926
201020
201125
201222
201316
201422
201529
201623
201730
201821
201924
202022
202136
202225
202324
202425
202523
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed277
Unknown status72
Terminated60
Active, not recruiting57
Recruiting53
Withdrawn5
Not yet recruiting5
Enrolling by invitation2
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore76
Novartis Pharmaceuticals62
National Cancer Centre, Singapore36
Singapore General Hospital27
Bristol-Myers Squibb19
GlaxoSmithKline17
Bayer16
Hoffmann-La Roche16
Boehringer Ingelheim12
National Cancer Institute (NCI)11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung43
Breast Neoplasms42
Stomach Neoplasms20
Carcinoma, Hepatocellular19
Hepatitis B15
Neoplasms15
Hepatitis B, Chronic14
Nasopharyngeal Carcinoma14
Neoplasm Metastasis14
Head and Neck Neoplasms12

Trials

Showing 1 to 25 of 533. Each trial links to its page on Pharma Observatory.

433 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.